PortfoliosLab logo

Adaptive Biotechnologies Corporation (ADPT)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Adaptive Biotechnologies Corporation in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,988 for a total return of roughly -80.12%. All prices are adjusted for splits and dividends.

ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADPT

Popular comparisons: ADPT vs. SPY


Adaptive Biotechnologies Corporation had a return of 4.84% year-to-date (YTD) and -30.77% in the last 12 months. Over the past 10 years, Adaptive Biotechnologies Corporation had an annualized return of -35.24%, while the S&P 500 had an annualized return of 8.17%, indicating that Adaptive Biotechnologies Corporation did not perform as well as the benchmark.

1 month-7.72%-5.31%
6 months-5.09%0.39%
1 year-30.77%-10.12%
5 years (annualized)-35.24%8.17%
10 years (annualized)-35.24%8.17%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.34. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Dividend History

Adaptive Biotechnologies Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adaptive Biotechnologies Corporation is 90.76%, recorded on Oct 14, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-90.76%Jan 25, 2021436Oct 14, 2022
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203
-0.85%Jan 15, 20211Jan 15, 20211Jan 19, 20212
-0.71%Jan 20, 20211Jan 20, 20212Jan 22, 20213

Volatility Chart

Current Adaptive Biotechnologies Corporation volatility is 62.68%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)